NCT01540799View on ClinicalTrials.gov

Pathway M-1: Sphenopalatine Ganglion Stimulation for the AcuteTreatment of High Disability Migraine Headache

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
High Frequency, High Disability Migraine
Interventions
DEVICE

ATI Neurostimulation System

ATI Neurostimulator (NS-100) and Remote Controller (RC-200)

Trial Locations (3)

46010

Servicio de Neurologia, Hospital Clinico Universitario, Valencia

Unknown

Dept. of Neurology, K12 Bldg. 1st fl, De Pintelaan 185 B-9000, Ghent

DK-2600

Danish Headache Center & Department of Neurology, Glostrup Hospital, University of Copenhagen, Glostrup Municipality

Sponsors
All Listed Sponsors
lead

Autonomic Technologies, Inc.

INDUSTRY

NCT01540799 - Pathway M-1: Sphenopalatine Ganglion Stimulation for the AcuteTreatment of High Disability Migraine Headache | Biotech Hunter | Biotech Hunter